Oral Magnesium Supplementation in Chronic Kidney Disease Stages 3 and 4: Efficacy, Safety, and Effect on Serum Calcification Propensity—A Prospective Randomized Double-Blinded Placebo-Controlled Clinical Trial

INTRODUCTION: Chronic kidney disease (CKD) is associated with high cardiovascular morbidity and mortality. Recent evidence suggests that increases in both serum and intracellular magnesium (Mg) can slow or even prevent the development of vascular calcification seen in CKD. Serum calcification propen...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Kidney Int Rep
Päätekijät: Bressendorff, Iain, Hansen, Ditte, Schou, Morten, Silver, Burton, Pasch, Andreas, Bouchelouche, Pierre, Pedersen, Lise, Rasmussen, Lars Melholt, Brandi, Lisbet
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Elsevier 2016
Aiheet:
Clinical Research
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC5678662/
https://ncbi.nlm.nih.gov/pubmed/29142966
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ekir.2016.12.008
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia